Modulating the endotheliopathy of trauma: Factor concentrate versus fresh frozen plasma

Journal of Trauma and Acute Care Surgery

Volumn 80, Issue 4, 2016, Pages 576-585

  Pati, Shibani ^a,b   Potter, Daniel R ^a,b   Baimukanova, Gyulnar ^a,b   Farrel, David H ^d   Holcomb, John B ^c   Schreiber, Martin A ^d   Francisco, San ^a  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Coagulant function; FFP; Hemorrhagic shock; Kcentra; vascular permeability

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; VASCULOTROPIN A; BLOOD CLOTTING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIOPATHY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ERYTHROCYTE; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INJURY; LAPAROTOMY; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLASMA TRANSFUSION; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; ADHERENS JUNCTION; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; DISEASE MODEL; DRUG EFFECTS; EXSANGUINATION; IMMUNOHISTOCHEMISTRY; LUNG; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA; SHOCK, HEMORRHAGIC; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADHERENS JUNCTIONS; ANIMALS; BLOOD COAGULATION FACTORS; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EXSANGUINATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; LUNG; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PLASMA; SHOCK, HEMORRHAGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84955613207     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000961     Document Type: Conference Paper

References (37)

1. Holcomb JB, Fox EE, Wade CE. The Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study. J Trauma Acute Care Surg. 2013;75(Suppl 1):S1-S2.
2. del Junco DJ, Holcomb JB, Fox EE, Brasel KJ, Phelan HA, Bulger EM, Schreiber MA, Muskat P, Alarcon LH, Cohen MJ, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg. 2013;75(Suppl 1):S24-S30.
3. Brakenridge SC, Phelan HA, Henley SS, Golden RM, Kashner TM, Eastman AE, Sperry JL, Harbrecht BG, Moore EE, Cuschieri J, et al. Early blood product and crystalloid volume resuscitation: risk association with multiple organ dysfunction after severe blunt traumatic injury. J Trauma. 2011;71(2):299-305.
4. Haider AH, Piper LC, Zogg CK, Schneider EB, Orman JA, Butler FK, Gerhardt RT, Haut ER, Mather JP, MacKenzie EJ, et al. Military-to-civilian translation of battlefield innovations in operative trauma care. Surgery. 2015;158(6):1686-1695.
5. Kim BD, Zielinski MD, Jenkins DH, Schiller HJ, Berns KS, Zietlow SP. The effects of prehospital plasma on patients with injury: a prehospital plasma resuscitation. J Trauma Acute Care Surg. 2012;73(2 Suppl 1):S49-S53.
6. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-482.
7. Imam AM, Jin G, Sillesen M, Duggan M, Jepsen CH, Hwabejire JO, Lu J, Liu B, DeMoya MA, Velmahos GC, et al. Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2013;75 (6):976-983.
8. Potter DR, Baimukanova G, Keating SM, Deng X, Chu JA, Gibb SL, Peng Z, Muench MO, Fomin ME, Spinella PC, et al. Fresh frozen plasma and spray-dried plasma mitigate pulmonary vascular permeability and inflammation in hemorrhagic shock. J Trauma Acute Care Surg. 2015;78(6 Suppl 1): S7-S17.
9. Peng Z, Pati S, Potter D, Brown R, Holcomb JB, Grill R, Wataha K, Park PW, Xue H, Kozar RA. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock. 2013;40(3):195-202.
10. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, Kozar RA, Hartwell E, Conyers J, Holcomb JB. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69(Suppl 1):S55-S63.
11. Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg. 2015;78(6 Suppl 1):S83-S86.
12. Alam HB, Hamwi KB, Duggan M, Fikry K, Lu J, Fukudome EY, Chong W, Bramos A, Kim K, Velmahos G. Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. J Trauma. 2011;70(3):636-645.
13. Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program. 2013;2013:656-659.
14. Jenkins DH, Rappold JF, Badloe JF, Berseus O, Blackbourne L, Brohi KH, Butler FK, Cap AP, Cohen MJ, Davenport R, et al. Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice and knowledge gaps. Shock. 2014;41 (Suppl 1):3-12.
15. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One. 2011;6(8:e23530).
16. Peng Z, Ban K, Sen A, Grill R, Park P, Costantini TW, Kozar R. Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut. Shock. 2012;38(1):57-62.
17. Imam AM, Jin G, Duggan M, Sillesen M, Hwabejire JO, Jepsen CH, DePeralta D, Liu B, Lu J, deMoya MA, et al. Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock. Surgery. 2013;154 (2):388-396.
18. Schenk S, Schoenhals GJ, de Souza G, Mann M. A high confidence manually validated human blood plasma protein reference set. BMC Med Genomics. 2008;1:41.
19. Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority randomised trial. Lancet. 2015;385(9982):2077-2087.
20. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55.
21. Giaever I, Keese CR. Use of electric fields to monitor the dynamical aspect of cell behavior in tissue culture. IEEE Trans Biomed Eng. 1986; 33(2):242-247.
22. Keese CR, Bhawe K, Wegener J, Giaever I. Real-time impedance assay to follow the invasive activities of metastatic cells in culture. Biotechniques. 2002;33(4):842-4, 6, 8-50.
23. Cabrales P, Tsai AG, Ananda K, Acharya SA, Intaglietta M. Volume resuscitation from hemorrhagic shock with albumin and hexapegylated human serum albumin. Resuscitation. 2008;79(1):139-146.
24. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86(1):279-367.
25. Benest AV, Kruse K, Savant S, Thomas M, Laib AM, Loos EK, Fiedler U, Augustin HG. Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS One. 2013;8(8);e70459.
26. Brkovic A, Sirois MG. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and no synthesis. J Cell Biochem. 2007;100(3):727-737.
27. Newman PJ, Aster R, Boylan B. Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. J Thromb Haemost. 2007;5(Suppl 1):305-309.
28. Joseph B, Pandit V, Khalil M, Kulvatunyou N, Aziz H, Tang A, O'Keeffe T, Hays D, Gries L, Lemole M, et al. Use of prothrombin complex concentrate as an adjunct to fresh frozen plasma shortens time to craniotomy in traumatic brain injury patients. Neurosurgery. 2015;76(5):601-607.
29. Joseph B, Aziz H, Pandit V, Hays D, Kulvatunyou N, Tang A, Wynne J, O'Keeffe T, Green DJ, Friese RS, et al Prothrombin complex concentrate use in coagulopathy of lethal brain injuries increases organ donation. Am Surg. 2014;80(4):335-338.
30. Joseph B, Hadjizacharia P, Aziz H, Kulvatunyou N, Tang A, Pandit V, Wynne J, O'Keeffe T, Friese RS, Rhee P. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg. 2013;74(1):248-253.
31. Joseph B, Amini A, Friese RS, Houdek M, Hays D, Kulvatunyou N, Wynne J, O'Keeffe T, Latifi R, Rhee P. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg. 2012;72(4):828-834.
32. Weidemann A, Johnson RS. Biologyof HIF-1alpha.Cell Death Differ. 2008; 15(4):621-627.
33. Zhang Y, Liang ZY, Zhang SY, Huang FF, Wu W, Gao Y, Chen ZB. Albumin resuscitation protects against traumatic/hemorrhagic shock-induced lung apoptosis in rats. J Zhejiang Univ Sci B. 2008;9(11):871-878.
34. Sperling R, Furie BC, Blumenstein M, Keyt B, Furie B. Metal binding properties of gamma-carboxyglutamic acid. Implications for the vitamin K-dependent blood coagulation proteins. J Biol Chem. 1978;253(11): 3898-3906.
35. Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled phase IIIb study. Circulation. 2013;128(11):1234-1243.
36. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypo-tensive patients with penetrating torso injuries. N Engl J Med. 1994; 331(17):1105-1109.
37. Schreiber MA, Meier EN, Tisherman SA, Kerby JD, Newgard CD, Brasel K, Egan D, Witham W, Williams C, Daya M, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78(4): 687-697.